| pubmed-article:3471317 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C0330390 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C0014442 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C0018183 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C0023473 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C0023516 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C0001128 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C0010715 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C0037039 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C0205307 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C0163611 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C2003941 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C1519042 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C0560013 | lld:lifeskim |
| pubmed-article:3471317 | lifeskim:mentions | umls-concept:C0150312 | lld:lifeskim |
| pubmed-article:3471317 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:3471317 | pubmed:dateCreated | 1987-6-25 | lld:pubmed |
| pubmed-article:3471317 | pubmed:abstractText | We have examined granulocytes from patients with chronic myelogenous leukemia (CML) and from normal subjects to determine whether activity of a specific sialyltransferase might account for the aberrant sialylation of O-linked membrane oligosaccharides in CML cells. Total membrane preparations of morphologically mature CML and normal granulocytes were tested for sialyltransferase activity using the substrates galactosyl-beta 1-3-N-acetyl-D-galactosamine-alpha-O-nitrophenyl and N-acetyl-D-galactosamine-alpha-phenyl. N-Acetyl-D-galactosamine-alpha-phenyl was not an acceptor with either CML or normal cells. With galactosyl-beta 1-3-N-acetyl-D-galactosamine-alpha-O-nitrophenyl, sialyltransferase activity was 2.8 times higher in CML cells compared to normal cells. Product identification by high performance liquid chromatography showed that enzyme from both normal and CML granulocytes linked sialic acid to galactosyl-beta 1-3-N-acetyl-D-galactosamine-R by the alpha(2-3) and not the alpha(2-6) linkage. The enzyme CMP-N-acetylneuraminic acid: galactosyl-beta 1-3-N-acetyl-D-galactosamine-R alpha(2-3)-sialyltransferase has not previously been described in human granulocytes. The marked increase in activity of this enzyme in CML and the resulting increase in sialylation may contribute to the pathophysiological behavior of CML granulocytes. | lld:pubmed |
| pubmed-article:3471317 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3471317 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3471317 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3471317 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3471317 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3471317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3471317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3471317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3471317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3471317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3471317 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3471317 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:3471317 | pubmed:issn | 0008-5472 | lld:pubmed |
| pubmed-article:3471317 | pubmed:author | pubmed-author:TaubR NRN | lld:pubmed |
| pubmed-article:3471317 | pubmed:author | pubmed-author:BakerM AMA | lld:pubmed |
| pubmed-article:3471317 | pubmed:author | pubmed-author:SchachterHH | lld:pubmed |
| pubmed-article:3471317 | pubmed:author | pubmed-author:BrockhausenII | lld:pubmed |
| pubmed-article:3471317 | pubmed:author | pubmed-author:HindenburgAA | lld:pubmed |
| pubmed-article:3471317 | pubmed:author | pubmed-author:KananiAA | lld:pubmed |
| pubmed-article:3471317 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3471317 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:3471317 | pubmed:volume | 47 | lld:pubmed |
| pubmed-article:3471317 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3471317 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3471317 | pubmed:pagination | 2763-6 | lld:pubmed |
| pubmed-article:3471317 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:3471317 | pubmed:meshHeading | pubmed-meshheading:3471317-... | lld:pubmed |
| pubmed-article:3471317 | pubmed:meshHeading | pubmed-meshheading:3471317-... | lld:pubmed |
| pubmed-article:3471317 | pubmed:meshHeading | pubmed-meshheading:3471317-... | lld:pubmed |
| pubmed-article:3471317 | pubmed:meshHeading | pubmed-meshheading:3471317-... | lld:pubmed |
| pubmed-article:3471317 | pubmed:meshHeading | pubmed-meshheading:3471317-... | lld:pubmed |
| pubmed-article:3471317 | pubmed:meshHeading | pubmed-meshheading:3471317-... | lld:pubmed |
| pubmed-article:3471317 | pubmed:meshHeading | pubmed-meshheading:3471317-... | lld:pubmed |
| pubmed-article:3471317 | pubmed:meshHeading | pubmed-meshheading:3471317-... | lld:pubmed |
| pubmed-article:3471317 | pubmed:meshHeading | pubmed-meshheading:3471317-... | lld:pubmed |
| pubmed-article:3471317 | pubmed:meshHeading | pubmed-meshheading:3471317-... | lld:pubmed |
| pubmed-article:3471317 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3471317 | pubmed:articleTitle | Presence of cytidine 5'-monophospho-N-acetylneuraminic acid:Gal beta 1-3GalNAc-R alpha(2-3)-sialyltransferase in normal human leukocytes and increased activity of this enzyme in granulocytes from chronic myelogenous leukemia patients. | lld:pubmed |
| pubmed-article:3471317 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3471317 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:3471317 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
